| 11/06/2026 7:40 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/05/2026 3:08 PM | Pulse Biosciences (1625101) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/14/2026 7:43 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/07/2026 8:06 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/15/2026 3:43 PM | Pulse Biosciences (1625101) Filer | Form 424B5 | |
| 09/15/2026 3:44 PM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/15/2026 7:54 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/02/2026 6:38 PM | Pulse Biosciences (1625101) Issuer Teplitsky Liane Rae (2132552) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/28/2026 6:41 PM | Pulse Biosciences (1625101) Issuer Teplitsky Liane Rae (2132552) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 08/28/2026 6:45 PM | Pulse Biosciences (1625101) Issuer Teplitsky Liane Rae (2132552) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/28/2026 6:48 PM | Pulse Biosciences (1625101) Issuer Teplitsky Liane Rae (2132552) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for PLSE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/28/2026 6:14 PM | Pulse Biosciences (1625101) Issuer Skinner Jon (2078637) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 08/28/2026 6:17 PM | Pulse Biosciences (1625101) Issuer Skinner Jon (2078637) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2026 4:04 PM | Pulse Biosciences (1625101) Filer | Form 424B5 | |
| 08/06/2026 4:04 PM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/06/2026 3:06 PM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/15/2026 8:21 PM | Pulse Biosciences (1625101) Issuer Zanganeh Mahkam (1507650) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 7:54 PM | Pulse Biosciences (1625101) Issuer Sainz Maria (1437768) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 8:03 PM | Pulse Biosciences (1625101) Issuer Soni Manmeet Singh (1569769) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 8:05 PM | DUGGAN ROBERT W (1055919) Reporting Pulse Biosciences (1625101) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 8:06 PM | Pulse Biosciences (1625101) Issuer van den Broek Richard (1431872) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 3:05 PM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/10/2026 7:55 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 6:25 PM | DUGGAN ROBERT W (1055919) Reporting Pulse Biosciences (1625101) Issuer | Form 4/A | |
| 05/14/2026 8:02 AM | Pulse Biosciences (1625101) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/13/2026 5:36 PM | DUGGAN ROBERT W (1055919) Filed by Pulse Biosciences (1625101) Subject | Form SCHEDULE 13D/A | |
| 05/11/2026 7:52 PM | LAVIOLETTE PAUL A (1191249) Reporting Pulse Biosciences (1625101) Issuer | Form 4/A | |
| 05/11/2026 5:53 PM | LAVIOLETTE PAUL A (1191249) Reporting Pulse Biosciences (1625101) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 5:52 PM | DUGGAN ROBERT W (1055919) Reporting Pulse Biosciences (1625101) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 8:17 AM | Pulse Biosciences (1625101) Filer | Form DEF 14A | |
| 05/06/2026 8:05 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/04/2026 8:16 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/27/2026 8:18 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/16/2026 8:00 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/09/2026 8:16 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/07/2026 7:59 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/03/2026 4:27 PM | Pulse Biosciences (1625101) Issuer UECKER DARRIN (1276311) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 3:32 PM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/17/2026 7:59 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/12/2026 8:20 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 8:31 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
The Democrats can’t stop this (Ad) Porter Stansberry believes President Trump has begun a full dollar reset through executive order 14241, bypassing Congress under a national emergency.
His new briefing outlines three steps to prepare and names a core group of assets tied to the initiative that he says could surge.
He points to the 1970s Nixon-era reset, which reportedly minted an average of 1,300 new millionaires a day for over half a century. Get Porter Stansberry's briefing on Trump's new dollar and the three steps he outlines. |
| 03/02/2026 8:21 AM | Pulse Biosciences (1625101) Filer | Form 8-K/A | |
| 03/01/2026 11:15 PM | Pulse Biosciences (1625101) Filer | Form EFFECT | |
| 02/27/2026 4:26 PM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/23/2026 7:55 PM | Danahy Kevin Patrick (1913245) Reporting Pulse Biosciences (1625101) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 3:19 PM | Pulse Biosciences (1625101) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/19/2026 3:22 PM | Pulse Biosciences (1625101) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 02/19/2026 3:08 PM | Pulse Biosciences (1625101) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/19/2026 3:09 PM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 7:47 PM | Danahy Kevin Patrick (1913245) Reporting Pulse Biosciences (1625101) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 6:46 PM | Danahy Kevin Patrick (1913245) Reporting Pulse Biosciences (1625101) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 8:21 PM | Pulse Biosciences (1625101) Issuer Sainz Maria (1437768) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 8:18 PM | Pulse Biosciences (1625101) Issuer Sainz Maria (1437768) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/14/2026 8:00 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 8:11 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/18/2025 8:00 AM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/12/2025 3:04 PM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/09/2025 3:04 PM | Pulse Biosciences (1625101) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |